Marion K.
- Country
- Germany
- Department
- Klinik und Poliklinik für Frauenheilkunde
Research Overview
- Efficacy and Safety of Fezolinetant in Treating Vasomotor Symptoms in Hormone Receptor-Positive Breast Cancer Patients on Adjuvant Endocrine Therapy
- A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA non-mutated Advanced Epithelial Ovarian Cancer (EOC) (KEYLYNK-001 / ENGOT-ov43 / GOG-3036)
Data & Insights
Has run more than one trial at 4 of 140 partner sites.
Specializations
Women's Health and Oncology
The investigator specializes in treating breast cancer patients, with particular focus on managing treatment-related symptoms in patients receiving hormone therapy. Their research extends to addressing vasomotor symptoms in cancer survivors.
- Hormone Receptor-Positive Breast Cancer Management
- Treatment-Related Symptom Control
- Hot Flash Management in Cancer Patients
Their work encompasses comprehensive care approaches for breast cancer patients undergoing adjuvant endocrine therapy.
Gynecologic Oncology
The investigator focuses on advanced treatments for epithelial ovarian cancer, exploring innovative therapeutic combinations. Their expertise includes the implementation of targeted therapies and immunotherapy approaches.
- Advanced Ovarian Cancer Treatment
- Combined Therapeutic Strategies
- First-line Treatment Optimization
Their research involves evaluating novel treatment combinations for improving outcomes in advanced ovarian cancer patients.
Therapeutic Innovation
The investigator's work encompasses targeted therapeutic approaches in gynecologic and breast cancers, with emphasis on developing personalized treatment strategies. Their research includes evaluation of novel therapeutic agents and combinations.
- Treatment Response Assessment
- Novel Therapeutic Combinations
- Patient-Centered Outcomes
Their expertise extends to evaluating treatment efficacy through established clinical assessment criteria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.